Overview
Founding partner of Fengrui Capital, focusing on investment in the fields of hard technology, biomedicine, and consumer/TMT, has extensive experience in the field of venture capital, and has long-term research on macroeconomic trends. Prior to founding Fengrui Capital, he worked for IDG Capital as a partner and member of the investment decision-making committee. Over the past nearly two decades, the projects responsible for investment and management have included Bilibili (Nasdaq listing, Hong Kong secondary listing), Yingshi Insta360 (Science and Technology Board listing), Xizhi Technology (Hong Kong Stock Exchange listing), Jingtai Technology (Hong Kong Stock Exchange listing), Fotye Technology (Hong Kong Stock Exchange listing), Yifei Technology (Hong Kong Stock Exchange listing), Three Squirrels (Shenzhen Stock Exchange listing), Unity (New York Stock Exchange listing), 360 Digital (Nasdaq listing, Hong Kong secondary listing), Bairong Yunchuang (Hong Kong Stock Exchange listing), Coinbase (Nasdaq listing), Zhidan Travel (Hong Kong Stock Exchange listing), etc. He holds a Bachelor of Science in Chemistry from Peking University and a Master of Science in Chemistry from the University of Rochester, USA.
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
峰瑞资本创始合伙人，专注于硬科技、生物医药、消费/TMT领域的投资，在风险投资领域有丰富的经验，对宏观经济趋势有长期的研究。创立峰瑞资本之前，任职于IDG资本，担任合伙人和投资决策委员会成员。过去近二十年，负责投资和管理的项目包括Bilibili（纳斯达克上市、港股二次上市）、影石Insta360（科创板上市）、曦智科技（港交所上市）、晶泰科技（港交所上市）、剂泰科技（港交所上市）、翼菲科技（港交所上市）、三只松鼠（深交所上市）、Unity（纽交所上市）、360数科（纳斯达克上市、港股二次上市）、百融云创（港交所上市）、Coinbase（纳斯达克上市）、嘀嗒出行（港交所上市）等。拥有北京大学化学理学学士学位和美国罗彻斯特大学化学理学硕士学位。